Rapid regression of atherosclerosis: insights from the clinical and experimental literature (Q37068628)

18 August 2017

1 reference

title

Rapid regression of atherosclerosis: insights from the clinical and experimental literature (English)

1 reference

18 August 2017

1 reference

Edward A Fisher

0 references

Kevin Jon Williams

1 reference

18 August 2017

Jonathan E Feig

series ordinal

1 reference

18 August 2017

language of work or name

1 reference

1 February 2008

1 reference

Nature Clinical Practice Cardiovascular Medicine

18 August 2017

published in

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

18 August 2017

page(s)

91-102

1 reference

Intravenously administered lecithin liposomes: a synthetic antiatherogenic lipid particle

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

Remodeling and shuttling. Mechanisms for the synergistic effects between different acceptor particles in the mobilization of cellular cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

The response-to-retention hypothesis of early atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

Development of the lipid-rich core in human atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

Does therapeutic intervention achieve slowing of progression or bona fide regression of atherosclerotic lesions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Role of oxidative modifications in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Evidence for a Monoclonal Origin of Human Atherosclerotic Plaques

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Studies of regression of advanced atherosclerosis in experimental animals and man

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Resolution of aortic atherosclerotic infiltration in the rabbit by phosphatide infusion

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Evidence of regression of atherosclerosis in primates and man

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Experimental models of atherosclerosis regression

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Nutritional control of coronary artery atherosclerosis in the squirrel monkey

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Regression of Coronary Atheromatosis in Rhesus Monkeys

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Lipoprotein retention--and clues for atheroma regression

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Uptake of endogenous cholesterol by a synthetic lipoprotein

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Large versus small unilamellar vesicles mediate reverse cholesterol transport in vivo into two distinct hepatic metabolic pools. Implications for the treatment of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Rapid restoration of normal endothelial functions in genetically hyperlipidemic mice by a synthetic mediator of reverse lipid transport

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Structural and metabolic consequences of liposome-lipoprotein interactions.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Cholesterol mobilization and regression of atheroma in cholesterol-fed rabbits induced by large unilamellar vesicles

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed Rabbits

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Lipid lowering reduces proteolytic and prothrombotic potential in rabbit atheroma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Loss of heparan N-sulfotransferase in diabetic liver: role of angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Subphysiologic apolipoprotein E (ApoE) plasma levels inhibit neointimal formation after arterial injury in ApoE-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E (apoE) deficient mice by administration of a second generation [E1(-), E3(-), polymerase(-)] adenovirus vector expressing human apoE.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Immunoregulation of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Nuclear receptors and lipid physiology: opening the X-files

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Hypomorphic apolipoprotein E mice: a new model of conditional gene repair to examine apolipoprotein E-mediated metabolism

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Dyslipidemia and the vulnerable plaque

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Intima-media thickness: a tool for atherosclerosis imaging and event prediction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with sta

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Effects of torcetrapib in patients at high risk for coronary events

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Effect of torcetrapib on the progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Emerging role of high-density lipoprotein in the prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Subendothelial retention of atherogenic lipoproteins in early atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Lipoprotein lipase in the arterial wall: linking LDL to the arterial extracellular matrix and much more.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: evidence for a role of lipoprotein lipase

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Matrix metalloproteinases and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Dynamic aspects of cholesterol metabolism in different areas of the aorta and other tissues in man and their relationship to atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

The turnover of cholesterol in human atherosclerotic arteries

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Rapid reversal of endothelial dysfunction in hypercholesterolemic apolipoprotein E-null mice by recombinant apolipoprotein A-I(Milano)-phospholipid complex

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Low-density lipoprotein cholesterol in patients with stable coronary heart disease--is it time to shift our goals?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Illuminating HDL--is it still a viable therapeutic target?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Emerging Cardiovascular Therapeutics Cambridge, MA, USA June 10– 11, 2003

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1086

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO1086

1 reference

Dimensions Publication ID

18 August 2017

1039926847

0 references

1 reference